ABSTRACTS - World Psychiatric Association

CONTENTS
ESI SM TOP-CITED SCIENTIST LECTURES 1
TL1. The treatment gap in psychiatry 1
TL2. Psychiatric genetics: a current perspective 1
TL3. Bipolarity: a broad spectrum (spectra)
in search of treatment 1
TL4. Pharmacotherapy of binge eating disorder 1
TL5. Environmental causes of mental disorder 2
TL6. The causes of schizophrenia: the striatum
and the street 2
TL7. Long-term management of depression: the role
of pharmacotherapy and psychotherapies 2
TL8. What is a mood stabilizer 2
TL9. Medical burden in bipolar disorder 3
TL10. Getting the evidence for evidence based care
of depression: how to narrow the knowledge gap 3
UPDATE LECTURES 3
UL1. How do we choose medications
for psychiatric patients 3
UL2. Psychotherapies: what works for whom 3
UL3. Values-based practice and psychiatric
diagnosis: bringing values and evidence
together in policy, training and research 4
UL4. Recovery and positive psychology: empiricism
or attitude 4
UL5. Steps, challenges and mistakes to avoid in the
development of community mental health care:
a framework from experience 4
UL6 Early intervention in psychiatry 4
UL7. Improving cognitive performance and realworld
functioning in people with schizophrenia 5
UL8. Evidence-based comprehensive management
of bipolar disorder 5
UL9. Management of patients with co-occurring
substance abuse and severe mental disorder 5
UL10. Comprehensive management of borderline
personality disorder in ordinary clinical practice 5
UL11. Comparative efficacy, effectiveness
and cost-effectiveness of antipsychotics
in the treatment of schizophrenia 6
UL12. The art and science of switching antipsychotic
medications 6
UL13. Combined and sequential treatment
strategies in depression and anxiety disorders 7
UL14. Multimodal management of anorexia
and bulimia nervosa 7
UPDATE SYMPOSIA 7
US1. The evolving science and practice
of psychosocial rehabilitation 7
US2. Anxiety disorders: from dimensions
to targeted treatments 8
US3. Treatment advances in child psychiatry 9
US4. Outcome in bipolar disorders: new findings
and methodological challenges 9
US5. Management of medically unexplained
somatic symptoms 10
US6. The future of psychotherapies for psychoses 11
US7. Advances in the management
of treatment-resistant depression 12
US8. ICD-11 and DSM-V: work in progress 12
US9. Gender-related issues in psychiatric treatments 13
US10. Suicide prevention: integration of public
health and clinical actions 14
US11. Brain imaging in psychiatry: recent progress
and clinical implications 15
US12. Advances in the management
of treatment-resistant bipolar disorder 16
US13. Partnerships in mental health care 16
US14. Genomics and proteomics in psychiatry:
an update 17
US15. Patterns of collaboration between primary
care and mental health services 18
US16. Effectiveness and cost-effectiveness
of pharmacological treatments in psychiatry:
evidence from pragmatic trials 19
US17. Cognitive impairment: should it be part
of the diagnostic criteria for schizophrenia 20
US18. Cultural issues in mental health care 21
US19. Advances in the management
of treatment-resistant psychotic disorders 22
US20. Violence, trauma and victimization 23
US21. The challenge of bipolar depression 23
US22. Novel biological targets of pharmacological
treatment in mental disorders 24
US23. Intermediate phenotypes in psychiatry 25
US24. Current management of mental disorders
in old age 26
US25. Prevention and early intervention strategies
in community mental health settings 27
US26. Managing comorbidity of mental
and physical illness 27
US27. Mental health care in low-resource countries 28
US28. Prevention of drug abuse: an international
perspective 29
REGULAR SYMPOSIA 30
RS1.
Interpersonal psychotherapy: history
and update 2009 30
I